Nucleic acid therapies: Targeted AAV vectors for efficient cardiovascular gene transfer
| Institution | Universitätsklinikum Hamburg-Eppendorf (UKE) |
|---|---|
| Project leader | Thomas Eschenhagen |
| Site | Hamburg/Kiel/Lübeck |
| Project type | Innovation Cluster |
| Funding | € 86.700,00 |
| Begin | 01.01.2024 |
| End | 31.12.2026 |
| Partnerprojekte |
|
Förderkennzeichen
81X2710199
Projektnummer
1827